SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Fresh ESMO oncology updates are drawing attention, including early ovarian-cancer data for Lillys investigational Sofe-M combination; traders also debate the pullback and upcoming earnings, with bullish breakout hopes countered by concerns about fading momentum and resistance.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Merck is drawing attention for its partnership with Moderna on the personalized mRNA melanoma vaccine, whose Phase 3 results showed reduced recurrence or death risk when added to Keytruda. Traders debate whether the positive data justify the excitement: some see validation for a broader cancer-vaccine platform and future Keytruda sales, while others point to high expectations, uncertain commercialization and a sell-the-news reaction.

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

SHIB is drawing attention amid a prolonged, choppy consolidation, with traders parsing technical levels and speculating about a possible meme-coin rebound. Some holders are accumulating and anticipating a breakout, while others are frustrated by the tokens stagnation and question its utility and prospects.

Kratos Defense & Security Solutions, Inc. engages in the provision of mission critical products, services and solutions for United States national security priorities. It operates through the Kratos Government Solutions (KGS) and Unmanned Systems (US) segments. The KGS segment consists of an aggregation of KGS operating segments, including microwave electronic products, space, satellite and cyber, training solutions. The US segment refers to the unmanned aerial, unmanned ground, unmanned seaborne and related command, control and communications system businesses. The company was founded on December 19, 1994, and is headquartered in Round Rock, TX.

Kratos Defense & Security Solutions Inc

KTOS is drawing attention for its steep selloff toward 52-week lows, despite reported contract wins, analyst upgrades, and past earnings beats. Traders debate whether the decline reflects an expensive valuation, insider selling, and concerns about turning demand and production growth into profitsor an overdone pullback in a defense and drone company with long-term growth prospects.

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It operates through the following segments: Materials and Magnetics. The Materials segment focuses on the operation of Mountain Pass, which produces refined rare earth oxides and related products, as well as rare earth concentrate products. The Magnetics segment is involved in the operation of Independence Facility, where the company began production of magnetic precursor products. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

MP Materials Corporation

Attention centers on rare-earth supply-chain tensions: traders cite reports of Chinese suppliers withholding shipments and view MP as a strategic U.S. producer, while debating whether U.S.China negotiations could ease restrictions and weaken that near-term tailwind. The reaction is mixed, with optimism about domestic magnets and MPs GM deliveries offset by concern over the stocks prolonged decline and slow execution.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

CVS Health Corp

Traders are focused on CVSs November 4 earnings report, with many positioning for a rebound after the stocks recent pullback and pointing to technical support. Others are wary of sellers and whether the shares can regain momentum ahead of the results.

Vanguard Index Funds - Vanguard Morningstar Total Stock Market ETF

Vanguard Total Stock Market ETF

VTI is drawing attention amid broad-market concerns about elevated rates, inflation, energy costs and a possible AI-led correction, with traders debating whether recent weakness signals deeper risk or a buying opportunity. Some favor long-term index investing and dollar-cost averaging, while others expect further volatility and declines.

Roblox Corp. engages in the provision of online gaming services. Its platform consists of Roblox Client, Roblox Studio, and Roblox Cloud. Roblox Client is an application that allows users to explore 3D digital worlds. Roblox Studio is the toolset that allows developers and creators to build, publish, and operate 3D experiences and other content accessed with Roblox Client. Roblox Cloud includes the services and infrastructure that power the human co-experience platforms. The company was founded by Erik Cassel and David B. Baszucki in March 2004 and is headquartered in San Mateo, CA.

Roblox Corporation - Ordinary Shares - Class A

Roblox Corp.

Roblox is drawing attention ahead of its third-quarter earnings report, with traders citing stronger engagement tied to viral hit Steal an Egg and the stocks move back above its 200-day moving average. Bulls see a recovery setup, while skeptics question growth and monetization and warn that the earnings report could bring volatility.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Speculation that U.S. regulators may temporarily allow compounding of certain peptides is driving attention, with traders viewing access as a potential growth opportunity for Hims & Hers. The community is divided: some expect the prospect to lift the stock, while others are frustrated that peptide-related headlines have not ended its range-bound, volatile trading.

Intellia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellias FDA-accepted BLA for lonvo-z, granted Priority Review for hereditary angioedema, is the main catalyst, with traders focused on the March 2027 decision and the therapys Phase 3 results. Bulls see a potential path toward commercialization and validation of the gene-editing platform, while bears point to cash needs, commercialization risks and volatile trading.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Genflow Biosciences Plc operates as a biotechnology company, which engages in the research and development of gene therapies to counteract the effects of aging and diseases associated with advanced age. The company was founded by Eric Leire in 2020 and is headquartered in London, the United Kingdom.

Genflow Biosciences Plc

Bearish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$0.045
Prev Close	$0.0289
Open	$0.045
Dividend Yield	0.00%
50-Day Moving Average	$0.0388
Beta	0.87
Avg. Volume	5,547.62
PE Ratio	-15.00

52-Week High	$0.0711
52-Week Low	$0.0139
Market Capitalization	$26.75M
EPS (Annual)	-$0.0044
Price to Book	102.27
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

GENFF Fundamentals